Plan B Approval Clears The Way For Von Eschenbach Confirmation
Executive Summary
FDA's decision to approve the emergency contraceptive Plan B for over-the-counter sale to women age 18 and older opens the door to a vote on FDA Acting Commissioner Andrew von Eschenbach's nomination to the permanent post
You may also be interested in...
Von Eschenbach Receiving HELP With GOP Nomination Hurdles
Senate Health, Education, Labor & Pensions committee members are working to end Republican holds on the nomination of FDA Acting Commissioner Andrew von Eschenbach to the permanent post
Von Eschenbach Receiving HELP With GOP Nomination Hurdles
Senate Health, Education, Labor & Pensions committee members are working to end Republican holds on the nomination of FDA Acting Commissioner Andrew von Eschenbach to the permanent post
Health Committee to vote on von Eschenbach
Senate Health Committee is scheduled to vote Sept. 20 on the nomination of Andrew von Eschenbach to be permanent commissioner of FDA, despite the prospect of future holds. Sen. David Vitter (R-La.) has threatened a hold to push for a drug importation program, while Sen. Jim DeMint (R-S.C.) may use a hold to protest the continued marketing of Danco Laboratories' abortifacient Mifeprex. Democratic Sens. Hillary Clinton (N.Y.) and Patty Murray (Wash.) recently released a hold on von Eschenbach following FDA's approval of the morning-after pill Plan B for OTC use (1"The Pink Sheet" Aug. 28, 2006, p. 9)...
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: